Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 743

1.

A meta-analysis of topical prostaglandin analogues intra-ocular pressure lowering in glaucoma therapy.

Denis P, Lafuma A, Khoshnood B, Mimaud V, Berdeaux G.

Curr Med Res Opin. 2007 Mar;23(3):601-8. Review.

PMID:
17355741
2.

Comparison of the effects of travoprost, latanoprost and bimatoprost on ocular circulation: a 6-month clinical trial.

Koz OG, Ozsoy A, Yarangumeli A, Kose SK, Kural G.

Acta Ophthalmol Scand. 2007 Dec;85(8):838-43. Epub 2007 Aug 2.

3.
4.

The effect of latanoprost, bimatoprost, and travoprost on circadian variation of intraocular pressure in patients with open-angle glaucoma.

Yildirim N, Sahin A, Gultekin S.

J Glaucoma. 2008 Jan-Feb;17(1):36-9. doi: 10.1097/IJG.0b013e318133fb70.

PMID:
18303382
5.

Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.

Stewart WC, Konstas AG, Nelson LA, Kruft B.

Ophthalmology. 2008 Jul;115(7):1117-1122.e1. Epub 2008 Feb 20.

PMID:
18082886
7.
8.

Efficacy and tolerability of prostaglandin analogs: a meta-analysis of randomized controlled clinical trials.

Aptel F, Cucherat M, Denis P.

J Glaucoma. 2008 Dec;17(8):667-73. doi: 10.1097/IJG.0b013e3181666557.

PMID:
19092464
9.

Comparison of the diurnal ocular hypotensive efficacy of travoprost and latanoprost over a 44-hour period in patients with elevated intraocular pressure.

Dubiner HB, Sircy MD, Landry T, Bergamini MV, Silver LH, Darell Turner F, Robertson S, Andrew RM, Weiner A, Przydryga J.

Clin Ther. 2004 Jan;26(1):84-91.

PMID:
14996520
10.

Patient persistency with ocular prostaglandin therapy: a population-based, retrospective study.

Reardon G, Schwartz GF, Mozaffari E.

Clin Ther. 2003 Apr;25(4):1172-85.

PMID:
12809964
11.
12.
13.

Circadian IOP-lowering efficacy of travoprost 0.004% ophthalmic solution compared to latanoprost 0.005%.

García-Feijoo J, Martínez-de-la-Casa JM, Castillo A, Méndez C, Fernández-Vidal A, García-Sánchez J.

Curr Med Res Opin. 2006 Sep;22(9):1689-97.

PMID:
16968572
14.

A 1-year study to compare the efficacy and safety of once-daily travoprost 0.004%/timolol 0.5% to once-daily latanoprost 0.005%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.

Topouzis F, Melamed S, Danesh-Meyer H, Wells AP, Kozobolis V, Wieland H, Andrew R, Wells D.

Eur J Ophthalmol. 2007 Mar-Apr;17(2):183-90.

PMID:
17415690
15.

Comparison of Travoprost and Bimatoprost plus timolol fixed combinations in open-angle glaucoma patients previously treated with latanoprost plus timolol fixed combination.

Centofanti M, Oddone F, Gandolfi S, Hommer A, Boehm A, Tanga L, Sangermani C, Sportelli V, Haustein M, Manni G, Rossetti L.

Am J Ophthalmol. 2010 Oct;150(4):575-80. doi: 10.1016/j.ajo.2010.05.003. Epub 2010 Aug 4.

PMID:
20688314
16.

A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma.

Noecker RS, Dirks MS, Choplin NT, Bernstein P, Batoosingh AL, Whitcup SM; Bimatoprost/Latanoprost Study Group.

Am J Ophthalmol. 2003 Jan;135(1):55-63.

PMID:
12504698
17.
18.

Comparing bimatoprost and travoprost in black Americans.

Noecker RJ, Earl ML, Mundorf TK, Silverstein SM, Phillips MP.

Curr Med Res Opin. 2006 Nov;22(11):2175-80.

PMID:
17076978
19.
20.

Brimonidine purite 0.1% versus brinzolamide 1% as adjunctive therapy to latanoprost in patients with glaucoma or ocular hypertension.

Day DG, Hollander DA.

Curr Med Res Opin. 2008 May;24(5):1435-42. doi: 10.1185/030079908X301848 . Epub 2008 Apr 9.

PMID:
18402717
Items per page

Supplemental Content

Write to the Help Desk